An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The clinical development of an inhibitor of cellular proteasome function suggests that compounds targeting other components of the ubiquitin-proteasome system might prove useful for the treatment of human malignancies. NEDD8-activating enzyme (NAE) is an essential component of the NEDD8 conjugation pathway that controls the activity of the cullin-RING subtype of ubiquitin ligases, thereby regulating the turnover of a subset of proteins upstream of the proteasome. Substrates of cullin-RING ligases have important roles in cellular processes associated with cancer cell growth and survival pathways. Here we describe MLN4924, a potent and selective inhibitor of NAE. MLN4924 disrupts cullin-RING ligase-mediated protein turnover leading to apoptotic death in human tumour cells by a new mechanism of action, the deregulation of S-phase DNA synthesis. MLN4924 suppressed the growth of human tumour xenografts in mice at compound exposures that were well tolerated. Our data suggest that NAE inhibitors may hold promise for the treatment of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“orthogonally confirmed dose-dependent KAT2A degradation by western blot, and demonstrated that this degradation can be rescued by pre-treatment with a UBA3/NAE1 inhibitor, MLN4924 (37), a proteasome inhibitor, bortezomib (38), and a competing CRBN ligand, pomalidomide (7) (Fig. 1D).”
From Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues (2026) · cites this paper as [37]
In the citing paper
“we cotreated cells with a proteasome inhibitor (bortezomib) or a NEDD8-activating enzyme E1 inhibitor (MLN-4924 32 ) and found that both inhibitors prevented degradation of BTK (Figure 2D).”
From Bruton tyrosine kinase degradation as a therapeutic strategy for cancer (2019) · cites this paper as [32]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Self-citationKobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Function and regulation of cullin–RING ubiquitin ligases
Petroski, M. D., & Deshaies, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1547 · Cited by 2,148
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543
Modification of Proteins by Ubiquitin and Ubiquitin-Like Proteins
Kerscher, O., Felberbaum, R., & Hochstrasser, M. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010605.093503 · Cited by 1,517
Winston, J. T., Strack, P., Beer-Romero, P., Chu, C. Y., Elledge, S. J., & Harper, J. W. (1999) · Genes & Development · doi:10.1101/gad.13.3.270 · Cited by 954
Duda, D. M., Borg, L. A., Scott, D. C., Hunt, H. W., Hammel, M., & Schulman, B. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.022 · Cited by 767
Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, R. C., & Conaway, J. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190332597 · Cited by 653
Velcade®: U.S. FDA Approval for the Treatment of Multiple Myeloma Progressing on Prior Therapy
Kane, R. C., Bross, P. F., Farrell, A. T., & Pazdur, R. (2003) · The Oncologist · doi:10.1634/theoncologist.8-6-508 · Cited by 628
Cited by
Items 301–400 of 1,005
YTHDF2 promotes mitotic entry and is regulated by cell cycle mediators
Fei, Q., Zou, Z., Roundtree, I. A., Sun, H., & He, C. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000664 · Cited by 99
Suppression of glioblastoma by targeting the overactivated protein neddylation pathway
Hua, W., Li, C., Yang, Z., Li, L., Jiang, Y., Yu, G., Zhu, W. P., Liu, Z., Duan, S., Chu, Y., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov066 · Cited by 90
Chen, J. J., Tsu, C. A., Gavin, J. M., Milhollen, M. A., Bruzzese, F. J., Mallender, W. D., Sintchak, M. D., Bump, N. J., Yang, X., Ma, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.279984 · Cited by 92
Self-citationZhang, C., Zhou, B. O., Gu, F., Liu, H., Wu, H., Yao, F., Zheng, H., Fu, H. Q., Chong, W., Cai, S., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.01.020 · Cited by 94
Global site-specific neddylation profiling reveals that NEDDylated cofilin regulates actin dynamics
Vogl, A. M., Phu, L., Becerra, R., Giusti, S. A., Verschueren, E., Hinkle, T. B., Bordenave, M. D., Adrian, M., Heidersbach, A. J., Yankilevich, P., et al. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0370-3 · Cited by 92
Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases
Vittal, V., Stewart, M. D., Brzovic, P. S., & Klevit, R. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.675165 · Cited by 88
Ismail, H. M., Yamamoto, K., Vincent, T. L., Nagase, H., Troeberg, L., & Saklatvala, J. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39099 · Cited by 97
Designed Semisynthetic Protein Inhibitors of Ub/Ubl E1 Activating Enzymes
Lu, X., Olsen, S. K., Capili, A. D., Cisar, J. S., Lima, C. D., & Tan, D. S. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9088549 · Cited by 88
CUL4A ubiquitin ligase: a promising drug target for cancer and other human diseases
Sharma, P. K., & Nag, A. (2014) · Open Biology · doi:10.1098/rsob.130217 · Cited by 99
Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis
Gupta, I., Singh, K., Varshney, N. K., & Khan, S. M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00011 · Cited by 93
Enzymatic Activity of the Scaffold Protein Rapsyn for Synapse Formation
Li, L., Cao, Y. W., Wu, H., Ye, X., Zhu, Z., Xing, G., Shen, C., Barik, A., Zhang, B., Xie, X., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.10.023 · Cited by 91
Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer
Barbier-Torres, L., Delgado, T. C., García-Rodríguez, J. L., Zubiete-Franco, I., Fernández-Ramos, D., Buqué, X., Cano, A., Juan, V. G.-D., Fernández-Domínguez, I., Lopitz-Otsoa, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3191 · Cited by 87
Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase
Sun, Y. N., & Li, H. (2012) · Protein & Cell · doi:10.1007/s13238-012-2105-7 · Cited by 90
Deregulated neddylation in liver fibrosis
Zubiete‐Franco, I., Fernández‐Tussy, P., Barbier‐Torres, L., Simón, J., Fernández‐Ramos, D., Lopitz‐Otsoa, F., Juan, V. G., de Davalillo, S. L., Duce, A. M., Iruzubieta, P., et al. (2016) · Hepatology · doi:10.1002/hep.28933 · Cited by 90
Zhou, L. Q., Yu, X., Li, M., Gong, G., Liu, W., Tian, L., Zuo, H., Li, W., Gao, F., & Liu, H. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.031 · Cited by 92
Jin, H., Liao, L., Park, Y., & Liu, Y. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213819110 · Cited by 86
p97/VCP promotes degradation of CRBN substrate glutamine synthetase and neosubstrates
Nguyen, T. V., Li, J., Lu, C.-C. (., Mamrosh, J. L., Lu, G., Cathers, B. E., & Deshaies, R. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700949114 · Cited by 85
A natural product-like inhibitor of NEDD8-activating enzyme
Leung, C., Chan, D. S., Yang, H., Abagyan, R. A., Lee, S. M., Zhu, G., Fong, W. F., & Ma, D. (2011) · Chemical Communications · doi:10.1039/c0cc04927a · Cited by 85
Comprehensive Survey of Chemical Libraries for Drug Discovery and Chemical Biology: 2009
Dolle, R. E., Bourdonnec, B. L., Worm, K., Morales, G. A., Thomas, C. J., & Zhang, W. (2010) · Journal of Combinatorial Chemistry · doi:10.1021/cc100128w · Cited by 85
Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors
LaPlante, G., & Zhang, W. (2021) · Cancers · doi:10.3390/cancers13123079 · Cited by 92
PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression
Filippone, A., Lanza, M., Mannino, D., Raciti, G., Colarossi, C., Sciacca, D., Cuzzocrea, S., & Paterniti, I. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03130-z · Cited by 92
Pan, W., Zhou, J.-J., Yu, C. Y., Xu, Y., Guo, L.-J., Zhang, H., Zhou, D., Song, F., & Fan, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.495069 · Cited by 87
Zhi, X., Zhao, D. H., Wang, Z., Zhou, Z., Wang, C., Chen, W., Liu, R., & Chen, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0562 · Cited by 85
Tomimatsu, N., Mukherjee, B., Harris, J. L., Boffo, F. L., Hardebeck, M. C., Potts, P. R., Khanna, K. K., & Burma, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.772475 · Cited by 91
Pagan, J. K., Marzio, A., Jones, M. V., Saraf, A., Jallepalli, P. V., Florens, L. A., Washburn, M. P., & Pagano, M. (2014) · Nature Cell Biology · doi:10.1038/ncb3076 · Cited by 84
A Gatekeeper Residue for NEDD8-Activating Enzyme Inhibition by MLN4924
Toth, J. I., Yang, L., Dahl, R. S., & Petroski, M. D. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.02.006 · Cited by 84
Abbas, T., Mueller, A. C., Shibata, E., Keaton, M., Rossi, M., & Dutta, A. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.003 · Cited by 84
Suppression of tumor angiogenesis by targeting the protein neddylation pathway
Yao, W.-T., Wu, J.-F., Yu, G.-Y., Wang, R., Wang, K., Li, L.-H., Chen, P., Jiang, Y.-N., He, C., Lee, H. W., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.21 · Cited by 84
Self-citationModeling of Human Uveal Melanoma in Zebrafish Xenograft Embryos
van der Ent, W., Burrello, C., Teunisse, A. F. A. S., Ksander, B. R., van der Velden, P. A., Jager, M. J., Jochemsen, A. G., & Snaar-Jagalska, E. B. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15202 · Cited by 84
Liu, J., Song, T., Zhou, W., Xing, L., Wang, S., Ho, M., Peng, Z., Tai, Y.-T., Hideshima, T., Anderson, K. C., et al. (2019) · Leukemia · doi:10.1038/s41375-018-0205-y · Cited by 83
Therapeutic advancement of benzothiazole derivatives in the last decennial period
Tariq, S., Kamboj, P., & Amir, M. (2018) · Archiv der Pharmazie · doi:10.1002/ardp.201800170 · Cited by 83
Du, Y., Chen, Y., Wang, Y., Chen, J., Lu, X., Zhang, L., Li, Y., Wang, Z., Ye, G., & Zhang, G. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0835 · Cited by 83
Khalife, J., Radomska, H. S., Santhanam, R., Huang, X., Neviani, P., Saultz, J. N., Wang, H., Wu, Y.-Z., Alachkar, H., Anghelina, M. I., et al. (2015) · Leukemia · doi:10.1038/leu.2015.106 · Cited by 86
Gu, Y., Kaufman, J. L., Bernal, L., Torre, C., Matulis, S. M., Harvey, R. D., Chen, J., Sun, S., Boise, L., & Lonial, S. (2014) · Blood · doi:10.1182/blood-2013-08-521914 · Cited by 87
The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functions
Cai, W., & Yang, H. (2016) · Cell Division · doi:10.1186/s13008-016-0020-7 · Cited by 89
DNA-encoded library-enabled discovery of proximity-inducing small molecules
Mason, J. W., Chow, Y. T., Hudson, L., Tutter, A., Michaud, G., Westphal, M. V., Shu, W., Ma, X., Tan, Z. Y., Coley, C. W., et al. (2024) · Nature Chemical Biology · doi:10.1038/s41589-023-01458-4 · Cited by 83
KLHL22 maintains PD-1 homeostasis and prevents excessive T cell suppression
Zhou, X. A., Zhou, J., Zhao, L., Yu, G., Zhan, J., Shi, C., Yuan, R., Wang, Y., Chen, C., Zhang, W., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004570117 · Cited by 84
Cereblon covalent modulation through structure-based design of histidine targeting chemical probes
Cruite, J. T., Dann, G. P., Che, J., Donovan, K. A., Ferrao, S., Ficarro, S. B., Fischer, E. S., Gray, N. S., Huerta, F., Kong, N. R., et al. (2022) · RSC Chemical Biology · doi:10.1039/d2cb00078d · Cited by 90
Yu, C. Y., Ji, S., Sha, Q., Sun, Q., & Fan, H. (2015) · Nature Communications · doi:10.1038/ncomms9017 · Cited by 91
FBXW7 Confers Radiation Survival by Targeting p53 for Degradation
Cui, D., Xiong, X., Shu, J., Dai, X.-Q., Sun, Y., & Zhao, Y. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.12.032 · Cited by 87
Cullin-RING Ligase 5: Functional characterization and its role in human cancers
Zhao, Y., Xiong, X., & Sun, Y. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.04.003 · Cited by 83
FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors
Nguyen‐Dien, G. T., Kozul, K., Cui, Y., Townsend, B., Kulkarni, P. G., Ooi, S. S., Marzio, A., Carrodus, N., Zuryn, S., Pagano, M., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022112767 · Cited by 85
Xiao, Z., Chang, J.-G., Hendriks, I. A., Sigurðsson, J. O., Olsen, J. V., & Vertegaal, A. C. O. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o114.044792 · Cited by 91
APC/C and SCF cyclin F Constitute a Reciprocal Feedback Circuit Controlling S-Phase Entry
Choudhury, R., Bonacci, T., Arceci, A., Lahiri, D., Mills, C. A., Kernan, J. L., Branigan, T. B., DeCaprio, J. A., Burke, D. J., & Emanuele, M. J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.058 · Cited by 83
Xu, J., Zhou, W., Yang, F., Chen, G., Li, H., Zhao, Y., Liu, P., Li, H., Tan, M., Xiong, X., et al. (2017) · Nature Communications · doi:10.1038/ncomms14002 · Cited by 85
Functional analysis of Cullin 3 E3 ligases in tumorigenesis
Cheng, J., Guo, J., Wang, Z. P., North, B. J., Tao, K., Dai, X., & Wei, W. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.11.001 · Cited by 84
SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression
Zhang, J., Chen, M., Zhu, Y., Dai, X., Dang, F., Ren, J., Ren, S., Shulga, Y. V., de Beça, F. F., Gan, W., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.11.035 · Cited by 83
Self-citationZhou, Q., Lin, W., Wang, C., Sun, F., Ju, S., Chen, Q., Wang, Y., Chen, Y., Li, H., Wang, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30559-2 · Cited by 89
Neddylation dysfunction in Alzheimer's disease
Chen, Y., Neve, R. L., & Liu, H. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01604.x · Cited by 83
Zhao, H., Bauzon, F., Fu, H., Lu, Z., Cui, J., Nakayama, K., Nakayama, K. I., Locker, J. D., & Zhu, L. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.021 · Cited by 80
Abidi, N., & Xirodimas, D. P. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0315 · Cited by 82
Targeting endogenous proteins for degradation through the affinity-directed protein missile system
Fulcher, L. J., Hutchinson, L. D., Macartney, T. J., Turnbull, C., & Sapkota, G. P. (2017) · Open Biology · doi:10.1098/rsob.170066 · Cited by 79
Zhong, H., Wang, W., Kang, T., Yan, H. M., Yang, Y., Xu, L., Wang, Y., Ma, D., & Leung, C. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00250 · Cited by 79
SHP2 deneddylation mediates tumor immunosuppression in colon cancer via the CD47/SIRPα axis
Li, Y., Zhou, H., Liu, P., Lv, D., Shi, Y., Tang, B., Xu, J., Zhong, T., Xu, W., Zhang, J., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162870 · Cited by 82
Self-citationDiscovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2
Hanley, R. P., Nie, D. Y., Tabor, J. R., Li, F., Sobh, A., Xu, C., Barker, N. K., Dilworth, D., Hajian, T., Gibson, E., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c01421 · Cited by 81
Gao, Q., Yu, G., Shi, J.-Y., Li, L.-H., Zhang, W., Wang, Z., Yang, L., Duan, M., Zhao, H., Wang, X., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2309 · Cited by 79
Neddylation plays an important role in the regulation of murine and human dendritic cell function
Mathewson, N. D., Toubai, T., Kapeles, S. R., Sun, Y., Oravecz-Wilson, K. I., Tamaki, H., Wang, Y., Hou, G., Sun, Y., & Reddy, P. R. (2013) · Blood · doi:10.1182/blood-2013-02-486373 · Cited by 83
NEDDylation promotes stress granule assembly
Jayabalan, A. K., Sanchez, A. R., Park, R. Y., Yoon, S. P., Kang, G., Baek, J., Anderson, P., Kee, Y., & Ohn, T. (2016) · Nature Communications · doi:10.1038/ncomms12125 · Cited by 84
Steffen, J., Vashisht, A. A., Wan, J., Jen, J. C., Claypool, S. M., Wohlschlegel, J. A., & Koehler, C. M. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-07-0545 · Cited by 85
UBE2G1 governs the destruction of cereblon neomorphic substrates
Lu, G., Weng, S., Matyskiela, M., Zheng, X., Fang, W., Wood, S., Surka, C., Mizukoshi, R., Lu, C.-C., Mendy, D., et al. (2018) · eLife · doi:10.7554/elife.40958 · Cited by 78
Self-citationPIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network
Reichermeier, K. M., Straube, R., Reitsma, J. M., Sweredoski, M. J., Rose, C. M., Moradian, A., den Besten, W., Hinkle, T., Verschueren, E., Petzold, G., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.12.013 · Cited by 78
Shao, Y., Liu, Z., Song, X., Sun, R., Zhou, Y., Zhang, D., Sun, H., Huang, J., Wu, C., Gu, W., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1318 · Cited by 78
Jazaeri, A. A., Shibata, E., Park, J.-H., Bryant, J. L., Conaway, M. R., Modesitt, S. C., Smith, P. G., Milhollen, M. A., Berger, A., & Dutta, A. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1028 · Cited by 78
Self-citationTong, S., Yang, S., Yu, H., Zhang, L., Xie, P., & Jiang, W. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-06098-y · Cited by 79
Benamar, M., Guessous, F., Du, K., Corbett, P., Obeid, J., Gioeli, D., Slingluff, C. L., & Abbas, T. (2016) · eBioMedicine · doi:10.1016/j.ebiom.2016.06.023 · Cited by 77
Anticancer drug discovery by targeting cullin neddylation
Yu, Q., Jiang, Y., & Sun, Y. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.09.005 · Cited by 81
Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease
Sherman, D. J., & Li, J. (2020) · Molecules · doi:10.3390/molecules25030671 · Cited by 84
Convergence of mammalian RQC and C-end rule proteolytic pathways via alanine tailing
Thrun, A., Garzia, A., Kigoshi-Tansho, Y., Patil, P. R., Umbaugh, C. S., Dallinger, T., Liu, J., Kreger, S., Patrizi, A., Cox, G. A., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.004 · Cited by 82
Development of inhibitors in the ubiquitination cascade
Zhang, W., & Sidhu, S. S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.11.003 · Cited by 86
Rauert‐Wunderlich, H., Siegmund, D., Maier, E., Giner, T., Bargou, R. C., Wajant, H., & Stühmer, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059292 · Cited by 85
Mudhasani, R., Tran, J. P., Retterer, C. J., Kota, K. P., Whitehouse, C. A., & Bavari, S. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005437 · Cited by 81
Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme
Lv, Z., Yuan, L., Atkison, J. H., Williams, K. M., Vega, R., Sessions, E. H., Divlianska, D. B., Davies, C., Chen, Y., & Olsen, S. K. (2018) · Nature Communications · doi:10.1038/s41467-018-07015-1 · Cited by 78
The NEDD8-activating enzyme inhibitor MLN4924 reduces ischemic brain injury in mice
Yu, H., Luo, H., Chang, L., Wang, S., Geng, X., Kang, L., Zhong, Y., Cao, Y., Wang, R., Yang, X., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111896119 · Cited by 80
Pathogenic Role of the CRL4 Ubiquitin Ligase in Human Disease
Lee, J., & Zhou, P. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00021 · Cited by 73
Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses
Simonis, N., Rual, J.-F. M., Lemmens, I. H., Boxus, M., Hirozane-Kishikawa, T., Gatot, J., Dricot, A., Hao, T., Vertommen, D., Legros, S., et al. (2012) · Retrovirology · doi:10.1186/1742-4690-9-26 · Cited by 80
A patent review of the ubiquitin ligase system: 2015–2018
Li, X., Ekinci, E., Rohondia, S. O., Wang, J., Liu, J., & Dou, Q. P. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1549229 · Cited by 80
Korrodi‐Gregório, L., Soto‐Cerrato, V., Vitorino, R. M. P., Fardilha, M., & Pérez‐Tomás, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165973 · Cited by 78
Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis
Wang, G., Chan, C., Gao, Y., & Lin, H. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10319 · Cited by 83
Vanderdys, V., Allak, A., Guessous, F., Benamar, M., Read, P. W., Jameson, M. J., & Abbas, T. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0083 · Cited by 81
Validation of NEDD8-Conjugating Enzyme UBC12 As a New Therapeutic Target in Lung Cancer
Li, L., Kang, J., Zhang, W., Cai, L., Wang, S., Liang, Y., Jiang, Y., Liu, X., Zhang, Y., Ruan, H., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.06.005 · Cited by 75
Structural basis for adenylation and thioester bond formation in the ubiquitin E1
Hann, Z. S., Ji, C., Olsen, S., Lu, X., Lux, M. C., Tan, D. S., & Lima, C. (2019) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1905488116 · Cited by 68
Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancer
Wang, M., Medeiros, B. C., Erba, H. P., DeAngelo, D. J., Giles, F. J., & Swords, R. T. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.550877 · Cited by 77
Abdi, K. M., Lai, C.-H., Páez, P., Lay, M., Pyun, J., & Kuo, C. T. (2018) · Nature Communications · doi:10.1038/s41467-018-03812-w · Cited by 75
Proteasome functional insufficiency in cardiac pathogenesis
Wang, X., Li, J., Zheng, H., Su, H., & Powell, S. R. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00714.2011 · Cited by 77
A NSD3-targeted PROTAC suppresses NSD3 and cMyc oncogenic nodes in cancer cells
Xu, C., Meng, F., Park, K., Storey, A. J., Gong, W., Tsai, Y., Gibson, E., Byrum, S. D., Li, D., Edmondson, R. D., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.08.004 · Cited by 77
UBXN7 docks on neddylated cullin complexes using its UIM motif and causes HIF1α accumulation
Bandau, S., Knebel, A., Gage, Z. O., Wood, N. T., & Alexandru, G. (2012) · BMC Biology · doi:10.1186/1741-7007-10-36 · Cited by 79
Understanding cullin-RING E3 biology through proteomics-based substrate identification
Harper, J. W., & Tan, M.-K. M. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r112.021154 · Cited by 66
Cullin-RING ligases in regulation of autophagy
Cui, D., Xiong, X., & Zhao, Y. (2016) · Cell Division · doi:10.1186/s13008-016-0022-5 · Cited by 77
Neddylation and deneddylation in cardiac biology.
Kandala, S., Kim, I., & Su, H. (2014) · Europe PMC (PubMed Central) · Cited by 88
Ding, S., Zhu, S., Ren, L., Feng, N., Song, Y., Ge, X., Li, B., Flavell, R. A., & Greenberg, H. B. (2018) · eLife · doi:10.7554/elife.39494 · Cited by 72
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
Stanchina, M., Soong, D., Zheng-Lin, B., Watts, J. M., & Taylor, J. (2020) · Cancers · doi:10.3390/cancers12113225 · Cited by 80
Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer
Liu, L., Wong, C. C., Gong, B., & Yu, J. Q. (2017) · Oncogene · doi:10.1038/onc.2017.313 · Cited by 81
Self-citationComposition, Roles, and Regulation of Cullin-Based Ubiquitin E3 Ligases
Choi, C. M., Gray, W. M., Mooney, S., & Hellmann, H. A. (2014) · The Arabidopsis Book · doi:10.1199/tab.0175 · Cited by 79
Toward a pathophysiology inspired treatment of VEXAS syndrome
Heiblig, M., Patel, B. A., Groarke, E. M., Bourbon, E., & Sujobert, P. (2021) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.09.001 · Cited by 76
Recruitment of FBXO22 for targeted degradation of NSD2
Nie, Y., Tabor, J. R., Li, J., Kutera, M., St‐Germain, J. R., Hanley, R. P., Wolf, E., Paulаkonis, E., Kenney, T. M. G., Duan, S., et al. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01660-y · Cited by 80
NEDD8 links cullin-RING ubiquitin ligase function to the p97 pathway
den Besten, W., Verma, R., Kleiger, G., Oania, R. S., & Deshaies, R. J. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2269 · Cited by 72
Zhou, Y., Chen, T., Li, X., Yang, M., Tang, S., Zhu, X., Gu, Y. H., Su, X., Meng, X., Li, W., et al. (2016) · eLife · doi:10.7554/elife.14087 · Cited by 71
RNA-binding protein 39: a promising therapeutic target for cancer
Xu, C., Chen, X., Zhang, X., Zhao, D., Dou, Z., Xie, X., Li, H., Yang, H., Li, Q., Zhang, H., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00598-7 · Cited by 78
Fu, D., & Wang, T. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01485-7 · Cited by 72
Defining E3 ligase–substrate relationships through multiplex CRISPR screening
Timms, R. T., Mena, E. L., Leng, Y., Li, M. Z., Tchasovnikarova, I. A., Koren, I., & Elledge, S. J. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01229-2 · Cited by 75
Metadata
- Authors
- Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., Cullis, C. A., Doucette, A., Garnsey, J. J., Gaulin, J. L., Gershman, R. E., Lublinsky, A. R., McDonald, A., Mizutani, H., Narayanan, U., Olhava, E. J., Peluso, S., Rezaei, M., Sintchak, M. D., Talreja, T., Thomas, M. P., Traore, T., Vyskocil, S., Weatherhead, G. S., Yu, J., Zhang, J., Dick, L. R., Claiborne, C. F., Rolfe, M., Bolen, J. B., & Langston, S. P.
- Affiliations
- Takeda Oncology (United States) (US)
- Corresponding author
- Soucy, Teresa A.
- ORCID
- Venue
- Nature
- Published
- 2009-04
- Volume
- 458
- Issue
- 7239
- Pages
- 732-736
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2076194625
- Cited by
- 1,990
- References
- 46
- Citations by year
- 2026: 110 · 2025: 120 · 2024: 156 · 2023: 126 · 2022: 137 · 2021: 155 · 2020: 170 · 2019: 149 · 2018: 112 · 2017: 105 · 2016: 108 · 2015: 98 · 2014: 99 · 2013: 100 · 2012: 100
- FWCI
- 32.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- NEDD8-activating enzyme, MLN4924, cullin-RING ubiquitin ligases, ubiquitin-proteasome system, proteasome inhibitors, cancer cell death, tumor xenografts, small molecule inhibitors, antitumour activity
- MeSH terms
- NEDD8 Protein, Animals, Antineoplastic Agents, Cells, Cultured, Cyclopentanes, Enzyme Inhibitors, Female, Humans, Neoplasms, Pyrimidines, Transplantation, Heterologous, Ubiquitins, Ubiquitin-Activating Enzymes, Cullin Proteins, Cell Line, Tumor, Mice, Proteasome Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.